Pandu Raharja-Liu is a Co-Founder & CTO at Panakeia. Panakeia provides comprehensive ‘omics' molecular analysis of patient tissues significantly faster and cheaper than other methods. They are creating AI-technology to provide biomarker information directly from H&E-stained tissue images. Panakeia offers results in minutes rather than executing multiple physical tests over several days or weeks.  Their offerings enhance both clinical diagnostics and drug development.